CRISPR-Edited Wheat: A Breakthrough in Reducing Carcinogenic Acrylamide
Scientists have developed a gene-edited variety of wheat that significantly reduces the formation of acrylamide, a toxic compound and probable carcinogen, during high-temperature cooking. By utilizing CRISPR/Cas9 technology, researchers at Rothamsted Research have managed to lower the levels of a key precursor in wheat without compromising the crop’s yield.
The Science Behind the Solution: Targeting Asparagine
Acrylamide is formed during everyday processes like baking, frying and toasting. This happens when free asparagine, an amino acid found in wheat, converts into the toxic compound under high heat. To combat this, researchers targeted the asparagine synthetase genes in Triticum aestivum cv. Cadenza.
The team focused on two specific genes: TaASN2 and TaASN1. By knocking out these genes, they were able to disrupt the production of free asparagine in the grain. The results were substantial:
- Single-edited lines: Targeting TaASN2 reduced free asparagine by 59%.
- Dual-edited lines: Targeting both TaASN2 and TaASN1 reduced free asparagine by up to 93%.
Impact on Food Safety and Consumer Health
The reduction of the precursor amino acid translates directly into safer food products. In trials published in the Plant Biotechnology Journal, the impact on finished goods was stark:
- Bread: One CRISPR-edited line produced bread with acrylamide concentrations below detectable limits. Other lines showed levels between 8% and 23% of the control samples after toasting.
- Biscuits: Products made from dual-edited wheat showed a 93% reduction in acrylamide compared to control samples.
Precision Editing vs. Traditional Breeding
The study highlighted a critical advantage of CRISPR technology over traditional chemical mutagenesis (TILLING). While TILLING can reduce asparagine, it often introduces random mutations that can harm the plant’s productivity.
| Method | Asparagine Reduction | Impact on Yield |
|---|---|---|
| CRISPR/Cas9 | Up to 93% | No effect on yield |
| TILLING (Chemical) | 50% | Nearly 25% yield penalty |
Key Takeaways for the Industry
- Regulatory Compliance: This development helps food producers meet evolving regulatory requirements regarding acrylamide levels in food.
- Nutritional Integrity: Research indicates that total seed nitrogen, an indicator of protein content, remained unaffected by the gene edits.
- European Milestone: This perform included Europe’s first field trial of genome-edited wheat, conducted between 2021 and 2022.
Looking Ahead
The ability to precisely edit crop genetics to remove carcinogens without sacrificing yield represents a significant step forward in food science. As regulations regarding genome-edited crops continue to evolve, particularly in the UK and Europe, this “ultra-low asparagine” wheat could pave the way for a new standard of safety in the global bakery and snack industries.